Faculty Information - MURAKAMI Terumi

（Last updated : 2026-06-04 11:49:16）

MURAKAMI Terumi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Pediatrics

Position Assistant Professor

■ Books

Chapter contribution　

Segawa disease (deficiency of GTP cyclohydrolase I) 2013/03/15

■ Published papers

1.	Original article	Nonrandomized Allocation of Steroid Therapy in Patients With Fukuyama Congenital Muscular Dystrophy: Study Protocol for a Phase II Clinical Trial 2025/09
2.	Original article	Cross-Sectional Study of the Association Between Plasma Brain Natriuretic Peptide Levels and Left Ventricular Shortening Fraction in Fukuyama Congenital Muscular Dystrophy 2025/05/28
3.	Original article	Urinary prostaglandin D2 and E2 metabolites are elevated with disease severity in patients with Fukuyama congenital muscular dystrophy. 2025/02
4.	Case report	GNAO1-Related Disorder in a Patient with Psychomotor Developmental Delay and Hypotonia 2022/04/25
5.	Original article	Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy. 2021/12/20
6.	Review article	A short form of gross motor function measure for Fukuyama congenital muscular dystrophy 2020/05
7.	Original article	Characteristic findings of skeletal muscle MRI in caveolinopathies. 2018/10
8.	Case report	National registry of patients with Fukuyama congenital muscular dystrophy in Japan. 2018/10
9.	Original article	Respiratory management of patients with Fukuyama congenital muscular dystrophy. 2016/03
10.	Case report	Different Responses to Enzyme Replacement Therapy in Two Patients with Childhood-onset Pompe Disease 2013/01
11.	Original article	Identification of a Duplication Breakpoint in the DMD Gene Using Array Comparative Genomic Hybridization 2013/01
12.	Original article	Insomnia in Patients with Fukuyama Congenital Muscular Dystrophy 2013/01
13.	Original article	Long-term and Low-dose Steroid Therapy for Cardiomyopathy in Duchenne Muscular Dystrophy Patients 2013/01
14.	Original article	Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy. 2012/04
15.	Original article	Close monitoring of initial enzyme replacement therapy in a patient with childhood-onset Pompe disease 2012/02
16.	Original article	High-density CT of muscle and liver may allow early diagnosis of childhood-onset Pompe disease 2012/02
17.	Original article	High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation. 2010/10
18.	Original article	Benefits of FK 506 for refractory eye symptoms in a young child with ocular myasthenia gravis 2009/09
19.	Original article	A novel POMT2 mutation causes mild congenital muscular dystrophy with normal brain MRI 2009/06
Display 5 items
Display all(19)

■ Academic conference presentation

1.	Characteristics of muscle weakness following Parvovirus B19 infection in Fukuyama Congenital Muscular Dystrophy （Speech，General） 2026/06/04
2.	Noncontrolled,nonblinded,multicenter collaborative phase 2 trial of steroid therapy in Fukuyama muscular dystrophy （Speech，General） 2026/06/04
3.	Study of upper limb function using Bioelectrical impedance analysis in Fukuyama congenital muscular dystrophy （Speech，General） 2024/06/01
4.	Study of dysphagia in Fukuyama congenital muscular dystrophy (FCMD) （Poster notice，General） 2023/10/06
5.	Sleep disorders in Fukuyama congenital muscular distrophy （Speech，General） 2023/05/27
6.	Study of dysphagia in Fukoyama congenital muscular dystrophy (FCMD) （Speech，General） 2023/05/27
7.	Long-term follow-up of skeletal muscle imaging in patients with childhood-onset Pompe disease （Speech，General） 2023/05/26
8.	Evaluation of essential trace elements in patients with Fukuyama congenital muscle dystrophy （Speech，General） 2023/04/16
9.	Characteristics of cardiac dysfunction in patients with Fukuyama congenital muscular dystrophy （Poster notice，General） 2022/10/14
10.	Characteristics of cardiac dysfunction in patients with Fukuyama congenital muscular dystrophy （Speech，General） 2022/08/27
11.	Characteristics of cardiac dysfunction in patients with Fukuyama congenital muscular dystrophy （Speech，General） 2022/06/03
12.	Correlation between BNP and NT-proBNP in muscular dystrophy (Second report) （Speech，General） 2022/06/03
13.	Family association questionnaire on "unmanageable troubled behaviors” in patients with FCMD （Speech，General） 2022/06/03
14.	A symptomatic female MTM1 mutation carrier with right-dominant asymmetric muscle weakness （Poster notice，General） 2021/05/29
15.	Correlation between BNP and NT-proBNP in muscular dystrophy （Speech，General） 2021/05/28
16.	Evaluation of essential trace elements in patients with Fukuyama congenital muscle dystrophy （Speech，General） 2021/05/28
17.	Recommendations for futurebpediatricians ~Diversifying needs for pediatricians （Speech，Panelist at Symposium/Workshop (Appointed)） 2021/04/16
18.	Actigraphy is valid for motor function assessment of Fukuyama congenital muscular dystrophy （Speech，General） 2020/08/19
19.	Efficacy evaluation of Nusinersen for spinal muscular atrophy type 1/2 using bioelectrical impedance （Speech，General） 2020/08/19
20.	Complications of Fukuyama congenital muscular dystrophy revealed from a nationwide registry （Poster notice，General） 2019/10/04
21.	Urinary titin fragment in Fukuyama congenital muscular dystrophy （Poster notice，General） 2019/10/04
22.	Characteristic findings of skeletal muscle MRI in Cavecolinopathies （Poster notice，General） 2019/10/02
23.	Characteristic skeletal muscle imuscle imaging patterns in Japanese patients with Pompe disease （Speech，Panelist at Symposium/Workshop (Appointed)） 2019/07/13
24.	Characteristic findings of skeletal muscle MRI in childhood-onset Cavecolinopathy （Speech，General） 2019/06/01
25.	Efficacy of corticosteroids therapy for Fukuyama congenital muscular dystrophy （Speech，General） 2019/05/31
26.	Urinary titin fragment in Fukuyama congenital muscular dystrophy （Speech，General） 2019/05/31
27.	Care and prevention of foot disorders in Bethelm myopathy patients （Poster notice，General） 2018/06/01
28.	Modified gross motor function measure for Fukuyama congenital muscular dystrophy （Speech，General） 2018/05/31
29.	Time-dependent change of Musce MRI STIR in Fukuyama congenital muscular dystrophy （Speech，General） 2017/10/14
30.	A Japanese nationwide survey on congenital myotonic dystrophy （Poster notice，General） 2017/05/13
31.	Relationship between inpedance obtained by BIA and MR Images of limbs of patients with Fukuyama congenital muscular dystrophy （Poster notice，General） 2017/05/13
32.	The gross motor function measure is valid for Fukuyama congenital muscular dystrophy （Poster notice，General） 2017/05/13
33.	Correlation between MRI STIR image of lower limbs and BIA in the natural course of FCMD patients （Speech，General） 2016/06/03
34.	Nationwide patient registry of Fukuyama congenital muscular dystrophy in Japan （Poster notice，General） 2016/06/03
35.	Our approach which aimed at ideal transition for muscular dystrophy patients to adult health care （Poster notice，General） 2016/06/03
36.	The gross motor function measure is a valid for Fukuyama congenital muscular dystrophy （Speech，General） 2016/06/03
37.	Time-dependent change of Muscle MRI STIR in Fukuyama congenital muscular dystrophy （Poster notice，General） 2016/06/03
38.	Effectiveness of levetiracetam for seizures in patients with Fukuyama congenital muscular dystrophy （Poster notice，General） 2014/10/09
39.	Natural history of motor function in patients with Fukuyama congenital muscular dystrophy （Poster notice，General） 2014/10/09
40.	Renal dysfunction in patients with Fukuyama congenital muscular dystrophy （Poster notice，General） 2014/10/09
41.	A new index of muscle development and disease progression for the pediatric patients with Duchenne muscular dystrophy, using bioelectrical impedance analysis: An observation study （Poster notice，General） 2014/10/08
42.	A new index of muscle development and disease progression for the pediatric patients with Fukuyama congenital muscular dystrophy, using bioelectrical impedance analysis; an observation study （Poster notice，General） 2014/10/08
43.	Skeletal muscle MRI in an X-linked myotubular myopathy patient who became ambulatory （Poster notice，General） 2014/10/07
44.	Skeletal muscle MRI with fat suppression technique can detect early changes in childhood onset Pompe disease in patients receiving ERT （Poster notice，General） 2014/09/27
45.	Chronic respiratory failure in patients with Fukuyama congenital muscular dystrophy （Poster notice，General） 2013/10/02
46.	Steroid Treatment for exacerbation of muscle weakness after viral infection in Fukuyama congenital muscular dystrophy （Poster notice，General） 2013/10/02
47.	Therapeutic intervention for dysphagia in patients with Fukuyama congenital muscular dystrophy （Poster notice，General） 2013/10/02
48.	Low-dose steroid therapy for cardiomyopathy in Duchenne Muscular Dystrophy patients （Poster notice，General） 2012/10/09
49.	Scoliosis in Fukuyama congenital muscular dystrophy(FCMD) patients （Poster notice，General） 2012/10/09
50.	Early progression of respiratory failure in a young firl with autosomal dominant Emery-Dreifuss muscular dystrophy. （Poster notice，General） 2012/09/07
51.	Skeleta muscle images in childhood-onset Pompe disease patients receiving enzyme replacement therapy (ERT) （Poster notice，General） 2012/09/07
52.	Efficacy of low-dose steroid therapy for scoliosis in patients with Duchenne muscular dystrophy （Poster notice，General） 2011/10/21
53.	Longitudinal study of skeletal muscle images in childhood-onset Pompe disease patients receiving enzyme replacement therapy(ERT) （Poster notice，General） 2011/10/20
54.	Early progression of respiratory failure in a young firl with autosomal dominant Emery-Dreifuss muscular dystrophy. （Speech，General） 2011/09/07
55.	Selection of isotonic saline as initial parenteral fluid therapy for children with either of high fever, vomiting and dyspnea （Speech，General） 2011/06/02
56.	Two Japanese girls with juvenile-onset tumefactive multiple sclerosis （Poster notice，General） 2011/05/13
57.	High density of skeletal muscle CT imaging indicates accumulation of calcium in autophagic vacules in childhood-onset Pompe disease （Speech，General） 2010/11/19
58.	High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation （Speech，General） 2010/10/23
59.	Severe muscle damage following viral infection in patients with Fukuyama congental muscular dystrophy （Speech，Panelist at Symposium/Workshop (Other)） 2010/10/23
60.	Cardiopathy form of α-dystroglycanopathy caused by FKTN mutation in Japan （Poster notice，General） 2010/10/12
61.	Clinical and electroencephalographic analysis in patients with Fukuyama congenital muscular dystrophy （Poster notice，General） 2010/10/12
62.	Severe muscle damage following viral infection in patients with Fukuyama type congenital muscular dystrophy(FCMD) （Poster notice，General） 2010/10/12
63.	Specific finding of high-density changes on skeletal muscle CT scan in childhood-onset Pompe disease （General） 2009/09/25
64.	High density on skeletal muscle CT imaging indicates accumulation of calcium in autophagic vacuoles in childhood-onset Pompe disease （Speech，Panelist at Symposium/Workshop (Appointed)） 2009/09/10
65.	Cardiac complication in LGMD 2L （Speech，Panelist at Symposium/Workshop (Appointed)） 2007/12/15
66.	Congenital myasthenic syndrome in Japan （Speech，Panelist at Symposium/Workshop (Appointed)） 2007/12/15
67.	Fukuyama congenital muscular dystrophy: Rhabdomyolysis induced by viral infection. （Speech，Panelist at Symposium/Workshop (Appointed)） 2007/12/15
68.	initial efficacy of enzyme replacement therapy for a patient with childhood-onset Pompe disease （Speech，Panelist at Symposium/Workshop (Appointed)） 2007/11/29
69.	The utility of skeletal muscle CT scan in childhood-onset Pompe disease （Poster notice，General） 2007/10/18
70.	Fukutin Gene Mutations Can Cause Familial Dilated Cardiomyopathy with Minimal Muscle Weakness and Normal Intelligence （Speech，General） 2007/01/24
71.	The First Japanese Patient with Congenital Myasthenic Syndrome with Acetylcholine Receptor Deficiency （Speech，General） 2007/01/24
72.	α-dystroglycanopathy in Japan （Speech，General） 2005/09/28
Display 5 items
Display all(72)

■ Education

1.	1995/04～2001/03	Faculty of Medicine, Tokyo Women's Medical University, Completed,
2.	2003/04～2007/03	〔Doctoral course〕〔Doctorial Course〕, Graduate School, Division of Medicine, Tokyo Women's Medical University, Completed,